# Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot

> **NCT01518478** · EARLY_PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 40 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Fluzone® Intradermal (Sanofi Pasteur Inc.)

## Key facts

- **NCT ID:** NCT01518478
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-02
- **Final completion:** 2012-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01518478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01518478, "Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01518478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*